Tsuji K, Uehara A, Okumura T, Taniguchi Y, Kitamori S, Takasugi Y, Namiki M
Department of Internal Medicine, Asahikawa Medical College, Hokkaido, Japan.
Eur J Pharmacol. 1992 Jan 14;210(2):213-5. doi: 10.1016/0014-2999(92)90674-s.
We have recently found that bacterial lipopolysaccharide (LPS) at minute doses inhibits the secretion of gastric acid and pepsin in rats. The present study was performed to examine the mechanism by which LPS exerts its antisecretory action. The i.p. injection of LPS resulted in a dose-dependent (40-4000 ng/kg) decrease in gastric acid output in pylorus-ligated rats. However, preinjection of indomethacin (2-10 mg/kg s.c.), an inhibitor of prostaglandin biosynthesis, prevented the LPS-induced inhibition of gastric secretion in a dose-related manner, while these concentrations of indomethacin by themselves did not affect gastric acid output. These results suggest that LPS requires an intact prostaglandin system to exhibit its inhibitory action on gastric secretion.
